3 min read Last Updated : Sep 27 2024 | 9:11 AM IST
Global brokerage UBS has raised concerns about weakening trends in the Indian and the US pharmaceutical markets. In its recent coverage initiation report, UBS said the pace of a decline in the US generic market is likely to worsen, while the growth of India pharma market has been slowing and recent trends of sharp increase in unbranded generics is a concern.
“These two markets account for 70-80 per cent of sector profits and…
Read More…